Skip to main content
    • Aa
    • Aa

Burden of Clostridium difficile Infection in Long-Term Care Facilities in Monroe County, New York

  • Deepa Pawar (a1), Rebecca Tsay (a1), Deborah S. Nelson (a1), Meena Kumari Elumalai (a1), Fernanda C. Lessa (a2), L. Clifford McDonald (a2) and Ghinwa Dumyati (a1)...

Long-term care facility (LTCF) residents are at increased risk of Clostridium difficile infection (CDI). However, little is known about the incidence, recurrence, and severity of CDI in LTCFs or the extent to which acute care exposure contributes to CDI in LTCFs. We describe the epidemiology of CDI in a cohort of LTCF residents in Monroe County, New York, where recent estimates suggest a CDI incidence in hospitals of 9.2 cases per 10,000 patient-days.


Population-based surveillance study.


Monroe County, New York.


LTCF residents with onset of CDI while in the LTCF or less than 4 calendar-days after hospital admission from the LTCF from January 1 through December 31, 2010.


We conducted surveillance for CDI in residents of 33 LTCFs. A CDI case was defined as a stool specimen positive for C. difficile obtained from a patient without a C. difficile-positive specimen in the previous 8 weeks; recurrence was defined as a stool specimen positive for C. difficile obtained between 2 and 8 weeks after the last C. difficile-positive stool specimen.


There were 425 LTCF-onset cases and 184 recurrences, which yielded an incidence of 2.3 cases per 10,000 resident-days (interquartile range [IQR], 1.2–3.3) and a recurrence rate of 1.0 case per 10,000 resident-days (IQR, 0.3–1.4). The cases occurred in 394 LTCF residents, and 52% of these residents developed CDI within 4 weeks after hospital discharge. Hospitalization for CDI occurred in 70 cases (16%). Of those cases that involved hospitalization for CDI, 70% were severe CDI, and 23% ended in death within 30 days after hospital admission.


CDI incidence in Monroe County LTCFs is one-fourth the incidence among hospitalized patients. Approximately 50% of LTCF-onset cases occurred more than 4 weeks after hospital discharge, which emphasizes that prevention of CDI transmission should go beyond acute care settings.

Corresponding author
Johns Hopkins Preventive Medicine Residency Program, 615 North Wolfe Street, Room WB602, Baltimore, MD 21205 (
Hide All
1.Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459477.
2.Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334339.
3.Simor AE, Bradley SF, Strausbaugh LJ, Crossley K, Nicolle LE; SHEA Long-Term-Care Committee. Clostridium difficile in long-term care facilities for the elderly. Infect Control Hosp Epidemiol 2002;23:696703.
4.Crogan NL, Evans BC. Clostridium difficile, an emerging epidemic in nursing homes. Geriatr Nurs 2007;28:161164.
5.McDonald LC, Killgore GE, Thompson A, et al.An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:24332441.
6.Kelly CP, LaMont JT. Clostridium difficile: more difficult than ever. N Engl J Med 2008;359:19321940.
7.Simor AE. Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review. J Am Geriatr Soc 2010;58:15561564.
8.Henrich TJ, Krakower D, Bitton A, Yokoe DS. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 2009;15:415422.
9.Jones AL, Dwyer LL, Bercovitz AR, Strahan GW. The National Nursing Home Survey: 2004 overview. National Center for Health Statistics. Vital Health Stat 2009;13:1155.
10.Dubberke ER, Butler AM, Reske KA, et al.Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008;14:10311038.
11.Cohen SH, Gerding DN, Johnson S, et al.Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431455.
12.Kim JH, Toy D, Muder RR. Clostridium difficile infection in a long-term care facility: hospital-associated illness compared with long-term care-associated illness. Infect Control Hosp Epidemiol 2011;32:656660.
13.Department of Health and Human Services. Glossary: official U.S. Government site for Medicare. Accessed September 11, 2011.
14.Centers for Medicare and Medicaid Services. Certification and compliance: nursing homes. Accessed January 13, 2012.
15.McDonald LC, Coignard B, Dubberke E, et al.Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28:140145.
16.National Center for Health Statistics. Health, United States, 2011: with special feature on socioeconomic status and health. Hyattsville, MD. 2012.
17.New York State Department of Health. Hospital-acquired infections: New York State, 2010. Updated 2011. Accessed February 1, 2012.
18.Zilberberg MD, Tabak YP, Sievert DM, et al.Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals. Infect Control Hosp Epidemiol 2011;32:649655.
19.Benoit SR, McDonald LC, English R, Tokars JI. Automated surveillance of Clostridium difficile infections using BioSense. Infect Control Hosp Epidemiol 2011;32:2633.
20.Campbell RJ, Giljahn L, Machesky K, et al.Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol 2009;30:526533.
21.Pennsylvania Patient Safety Advisory. Clostridium difficile infections in nursing homes. Updated 2010. Accessed August 19, 2011.
22.Loo VG, Bourgault AM, Poirier L, et al.Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med 2011;365:16931703.
23.Louie TJ, Miller MA, Mullane KM, et al.Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011;364:422431.
24.Petrella LA, Sambol SP, Cheknis A, et al.Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 2012;55:351357.
25.Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis 2011;11:194.
26.Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 2012;67:742748.
27.Mylotte JM. Surveillance for Clostridium difficile-associated diarrhea in long-term care facilities: what you get is not what you see. Infect Control Hosp Epidemiol 2008;29:760763.
28.Eddi R, Malik MN, Shakov R, Baddoura WJ, Chandran C, Debari VA. Chronic kidney disease as a risk factor for Clostridium difficile infection. Nephrology (Carlton) 2010;15:471475.
29.James MT, Laupland KB, Tonelli M, et al.Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Arch Intern Med 2008;168:23332339.
30.Guerrero DM, Nerandzic MM, Jury LA, Chang S, Jump RL, Donskey CJ. Clostridium difficile infection in a Department of Veterans Affairs long-term care facility. Infect Control Hosp Epidemiol 2011;32:513515.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 0
Total number of PDF views: 45 *
Loading metrics...

Abstract views

Total abstract views: 246 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd October 2017. This data will be updated every 24 hours.